Shao-Hua Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shao-Hua Xie has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Junjie Huang
The Jockey Club School of Public Health and Primary Care, Faculty of Medicine the Chinese University of Hong Kong Hong Kong SAR China
2 shared publications - Martin Chi Sang Wong
The Jockey Club School of Public Health and Primary Care, Faculty of Medicine the Chinese University of Hong Kong Hong Kong SAR China
2 shared publications - Wanghong Xu
School of Public Health, Fudan University, Shanghai, China
2 shared publications Cedric Chu
Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong
1 shared publication- Chun Ho Ngai
Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China
1 shared publication - Eman Leung
JC School of Public Health and Primary Care The Chinese University of Hong Kong Hong Kong China
1 shared publication
Latest Publications
- Open Access
- 19 October 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (21) , 20544-20553
Prediction algorithm for gastric cancer in a general population: A validation study
Background: Worldwide, gastric cancer is a leading cause of cancer incidence and mortality. This study aims to devise and validate a scoring system based on readily available clinical data to predict the risk of gastric cancer in a large Chinese population.Methods: We included a total of 6,209,697 subjects aged between 18 and 70 years who have received upper digestive endoscopy in Hong Kong from 1997 to 2018. A binary logistic regression model was constructed to examine the predictors of gastric cancer in a derivation cohort (n = 4,347,224), followed by model evaluation in a validation cohort (n = 1,862,473). The algorithm's discriminatory ability was evaluated as the area under the curve (AUC) of the mathematically constructed receiver operating characteristic (ROC) curve.Results: Age, male gender, history of Helicobacter pylori infection, use of proton pump inhibitors, non-use of aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and statins were significantly associated with gastric cancer. A scoring of <= 8 was designated as "average risk (AR)". Scores at 9 or above were assigned as "high risk (HR)". The prevalence of gastric cancer was 1.81% and 0.096%, respectively, for the HR and LR groups. The AUC for the risk score in the validation cohort was 0.834, implying an excellent fit of the model.Conclusions: This study has validated a simple, accurate, and easy-to-use scoring algorithm which has a high discriminatory capability to predict gastric cancer. The score could be adopted to risk stratify subjects suspected as having gastric cancer, thus allowing prioritized upper digestive tract investigation.
- 19 October 2023
- Published by Wiley in Cancer Medicine
- Vol. 12 (21) , 20544-20553
Open AccessPrediction algorithm for gastric cancer in a general population: A validation study
Background: Worldwide, gastric cancer is a leading cause of cancer incidence and mortality. This study aims to devise and validate a scoring system based on readily available clinical data to predict the risk of gastric cancer in a large Chinese population.Methods: We included a total of 6,209,697 subjects aged between 18 and 70 years who have received upper digestive endoscopy in Hong Kong from 1997 to 2018. A binary logistic regression model was constructed to examine the predictors of gastric cancer in a derivation cohort (n = 4,347,224), followed by model evaluation in a validation cohort (n = 1,862,473). The algorithm's discriminatory ability was evaluated as the area under the curve (AUC) of the mathematically constructed receiver operating characteristic (ROC) curve.Results: Age, male gender, history of Helicobacter pylori infection, use of proton pump inhibitors, non-use of aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and statins were significantly associated with gastric cancer. A scoring of <= 8 was designated as "average risk (AR)". Scores at 9 or above were assigned as "high risk (HR)". The prevalence of gastric cancer was 1.81% and 0.096%, respectively, for the HR and LR groups. The AUC for the risk score in the validation cohort was 0.834, implying an excellent fit of the model.Conclusions: This study has validated a simple, accurate, and easy-to-use scoring algorithm which has a high discriminatory capability to predict gastric cancer. The score could be adopted to risk stratify subjects suspected as having gastric cancer, thus allowing prioritized upper digestive tract investigation.
- Open Access
IDDF2020-ABS-0140 Worldwide incidence and risk factors of oesophageal cancer by histological subtypes
Background Worldwide, oesophageal cancer is one of the most common cancers and a leading cause of cancer mortality. Owing to its aggressive disease nature and poor survival rate, it contributes to a substantial burden to global health and clinical practice. This study aimed to estimate the worldwide incidence and risk factors of oesophageal cancer by histological subtypes using data from 178 countries. Methods The data on the incidence of oesophageal cancer by histological types in 2018 were estimated from GLOBALCAN and Cancer Incidence in Five Continents (CI5). Age-standardized rates (ASRs) for oesophageal cancer incidence by histological subtypes were evaluated by Segi–Doll population. The prevalence of tobacco use, alcohol drinking, physical inactivity, obesity, diabetes, and lipid disorders for each country were retrieved from the Global Health Observatory. The association between the ratio of histological subtypes and risk factors was examined by multivariable linear regression. Results We estimated a total of 63,470 (12.6%) and 502,669 new cases of oesophageal adenocarcinoma (AC) and squamous cell carcinoma (SCC) in 2018, respectively. The incidence among males was 3.6-fold and 2.2-fold of that among females for AC and SCC, respectively. The highest AC:SCC ratio was found in the UK (ratio 2.880, ASR 7.5), New Zealand (2.667, 4.2), the Netherlands (2.536, 7.7), Bahrain (2.143, 0.9), and Canada (2.000, 3.7) among males (figure 1). As for females, the highest AC:SCC ratio was observed in Moldova (1.000, 0.2), the Netherlands (0.800, 1.2), Iceland (0.750; 0.5), the UK (0.700; 1.4), and Cyprus (0.667; 0.3). A higher AC:SCC ratio was associated with a higher prevalence of obesity (male: β 0.039, 95% CI 0.023 to 0.055; female: 0.009, 0.004 to 0.146) and high cholesterol (male: 0.028, 0.010 to 0.047; female: 0.011, 0.004 to 0.019); but a lower prevalence of tobacco use (male: -0.007, -0.014 to -0.001) and diabetes (male: 0.009, 0.004 to 0.146; female: -0.021, -0.038 to -0.003). The global ratio of age-standardized incidence for oesophageal adenocarcinoma and squamous cell carcinoma Conclusions While SCC is the predominant subtype of oesophageal cancer, the incidence of AC has surpassed SCC in a substantial proportion of countries, probably due to the increasing prevalence of obesity and metabolic disorders. Future research should investigate the reasons behind these epidemiological changes.
Open AccessIDDF2020-ABS-0140 Worldwide incidence and risk factors of oesophageal cancer by histological subtypes
Background Worldwide, oesophageal cancer is one of the most common cancers and a leading cause of cancer mortality. Owing to its aggressive disease nature and poor survival rate, it contributes to a substantial burden to global health and clinical practice. This study aimed to estimate the worldwide incidence and risk factors of oesophageal cancer by histological subtypes using data from 178 countries. Methods The data on the incidence of oesophageal cancer by histological types in 2018 were estimated from GLOBALCAN and Cancer Incidence in Five Continents (CI5). Age-standardized rates (ASRs) for oesophageal cancer incidence by histological subtypes were evaluated by Segi–Doll population. The prevalence of tobacco use, alcohol drinking, physical inactivity, obesity, diabetes, and lipid disorders for each country were retrieved from the Global Health Observatory. The association between the ratio of histological subtypes and risk factors was examined by multivariable linear regression. Results We estimated a total of 63,470 (12.6%) and 502,669 new cases of oesophageal adenocarcinoma (AC) and squamous cell carcinoma (SCC) in 2018, respectively. The incidence among males was 3.6-fold and 2.2-fold of that among females for AC and SCC, respectively. The highest AC:SCC ratio was found in the UK (ratio 2.880, ASR 7.5), New Zealand (2.667, 4.2), the Netherlands (2.536, 7.7), Bahrain (2.143, 0.9), and Canada (2.000, 3.7) among males (figure 1). As for females, the highest AC:SCC ratio was observed in Moldova (1.000, 0.2), the Netherlands (0.800, 1.2), Iceland (0.750; 0.5), the UK (0.700; 1.4), and Cyprus (0.667; 0.3). A higher AC:SCC ratio was associated with a higher prevalence of obesity (male: β 0.039, 95% CI 0.023 to 0.055; female: 0.009, 0.004 to 0.146) and high cholesterol (male: 0.028, 0.010 to 0.047; female: 0.011, 0.004 to 0.019); but a lower prevalence of tobacco use (male: -0.007, -0.014 to -0.001) and diabetes (male: 0.009, 0.004 to 0.146; female: -0.021, -0.038 to -0.003). The global ratio of age-standardized incidence for oesophageal adenocarcinoma and squamous cell carcinoma Conclusions While SCC is the predominant subtype of oesophageal cancer, the incidence of AC has surpassed SCC in a substantial proportion of countries, probably due to the increasing prevalence of obesity and metabolic disorders. Future research should investigate the reasons behind these epidemiological changes.
- 1 April 2017
- Published by Elsevier in Cancer Epidemiology
- Vol. 47, 114-117
Incidence trends in oesophageal cancer by histological type: An updated analysis in Sweden
- 1 April 2017
- Published by Elsevier in Cancer Epidemiology
- Vol. 47, 114-117
Incidence trends in oesophageal cancer by histological type: An updated analysis in Sweden